Top Markets
#1 Nesa Nesa +719.78%
#2 EXOD EXOD +22.78%
#3 Pons Pons +14.63%
#4 MetaDAO MetaDAO +13.02%
#5 Venom Venom +11.05%
#6 Status Status +9.00%
#7 PondCoin PondCoin +8.44%
#8 Wrapped NXM Wrapped NXM +7.88%
#9 Prom Prom +7.75%
#10 Ontology Gas Ontology Gas +7.38%
Coin of the day
Nesa Nesa
설정
언어
한국어
통화
USD
테마
Gan & Lee Pharmaceuticals. Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals.

603087
주식 순위 #3185
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
주가
$10.35
시가총액
$6.19B
변동 (1일)
3.79%
변동 (1년)
4.34%
국가
CN
거래 Gan & Lee Pharmaceuticals. (603087)

카테고리

Healthcare
Gan & Lee Pharmaceuticals. (603087)의 배당 이력
Gan & Lee Pharmaceuticals. (주식 심볼: 603087)은 총 0회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): 0.00
배당 수익률 (TTM): 0
Gan & Lee Pharmaceuticals. (603087)의 2026부터 2026까지 배당 지급 내역
연간 배당 지급
연도 배당금 (주식 분할 조정됨) 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
모든 배당 지급 목록
연도 배당금 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 지급
회사 배당 지급 횟수 국가
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
0.00%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
26.00%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
0.00%
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
173.00%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
0.00%
CH